Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study for Patients With Complicated Skin and Skin Structure Infections

ClinicalTrials.gov ID: NCT00514527

Public ClinicalTrials.gov record NCT00514527. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 6:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Nuvocid® (Oritavancin) at Single or Infrequent Doses for the Treatment of Complicated Skin and Skin Structure Infections (SIMPLIFI)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Two Phase III trials to demonstrate the efficacy and safety of oritavancin in the treatment of complicated skin and skin structure infections (cSSSI) have been completed. The pharmacokinetic profile of oritavancin in humans suggests that oritavancin has the potential to be used safely and effectively when given either as a single dose or as an infrequent dose for cSSSI. Data from animals support this theory. SIMPLIFI has been designed to evaluate the efficacy and safety of either a single dose of oritavancin or an infrequent dose of oritavancin (First dose on Day one with an option for a second dose on Day five) compared to the previously studied dosing regimen of 200mg oritavancin given once daily for 3 to 7 days.

Study identification

NCT ID
NCT00514527
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
294 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2007 (Type not available)
Primary completion
Apr 2008 (Actual)
Completion
May 2008 (Actual)
Last update posted
Aug 14, 2008

2007 – 2008

United States locations

U.S. sites
33
U.S. states
15
U.S. cities
32
Facility City State ZIP Site status
Targanta Recruiting Site Mobile Alabama 36617 —
Targanta Recruiting Site Anaheim California 92804 —
Targanta Recruiting Site Buena Park California 90620 —
Targanta Recruiting Site Chula Vista California 91911 —
Targanta Recruiting Site Hawaiian Gardens California 90716 —
Targanta Recruiting Site Long Beach California 90813 —
Targanta Recruiting Site Los Angeles California 90015 —
Targanta Recruiting Site Oceanside California 92056 —
Targanta Recruiting Site Rolling Hills Estates California 90274 —
Targanta Recruiting Site San Jose California 95124 —
Targanta Recruiting Site Torrance California 90509 —
Targanta Recruiting Site Atlantis Florida 33462 —
Targanta Recruiting Site Inverness Florida 34452 —
Targanta Recruiting Site Miami Florida 33136 —
Targanta Recruiting Site Columbus Georgia 31405 —
Targanta Recruiting Site Marietta Georgia 30060 —
Targanta Recruiting Site Savannah Georgia 31405 —
Targanta Recruiting Site Springfield Illinois 602701 —
Targanta Recruiting Site Indianapolis Indiana 46280 —
Targanta Recruiting Site Baton Rouge Louisiana 70808 —
Targanta Recruiting Site Lafayette Louisiana 70503 —
Targanta Recruiting Site New Orleans Louisiana 70112 —
Targanta Recruiting Site Cumberland Maryland 21502 —
Targanta Recruiting Site Detroit Michigan 48202 —
Targanta Recruiting Site Minneapolis Minnesota 55422 —
Targanta Recruiting Site Albany New York 12208-1901 —
Targanta Recruiting Site Columbus Ohio 43215 —
Targanta Recruiting Site Toledo Ohio 43608 —
Targanta Recruiting Site Jackson Tennessee 38301 —
Targanta Recruiting Site Arlington Texas 76012 —
Targanta Recruiting Site Houston Texas 77005 —
Targanta Recruiting Site Houston Texas 77055 —
Targanta Recruiting Site Salt Lake City Utah 84102 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 33 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00514527, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 14, 2008 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00514527 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →